Researchers have developed a soft artificial retina that helped blind mice respond to near-infrared light, a type of light ...

Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting activated ...

Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company ...

The retina, the thin layer of tissue at the back of the eye, is made up of photoreceptor cells that convert visible light ...

When preparing for cataract surgery in patients with retinal pathologies, ophthalmologists must be sure to set reasonable ...

Prevent Blindness, the nation's leading patient advocacy organization dedicated to protecting and preserving eye health, has ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Retinal diseases are among the fastest growing causes of blindness, having a profound impact on patients’ independence and ...

There may be some truth to the saying "the eyes are the window to the soul." Age-related changes are reflected in the retina, ...

Retinal age, derived from a single fundus photograph, is a biomarker of clinical aging, according to a study published online ...